IRF9 Antikörper (AA 1-393)
Kurzübersicht für IRF9 Antikörper (AA 1-393) (ABIN7569824)
Target
Alle IRF9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-393
-
Verwendungszweck
- Anti-IRF9 Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human IRF9 (Met1-Val393).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Andere Bezeichnung
- IRF9
-
Hintergrund
- Interferon regulatory factor 9,ISGF3G,IRF-9,ISGF-3 gamma,ISGF3 p48 subunit,Transcriptional regulator ISGF3 subunit gamma,IRF9,Interferon-stimulated gene factor 3 gamma,IFN-alpha-responsive transcription factor subunit,
-
UniProt
- Q00978
-
Pathways
- JAK-STAT Signalweg, Interferon-gamma Pathway, Hepatitis C
Target
-